Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2011.01.11
监事聚会事规则(2011年1月)
2011.01.11
关联生意决议制度(2011年1月)
2011.01.11
股东大聚会事规则(2011年1月)
2010.10.23
财务治理制度(2010年10月)
2010.10.23
财务认真人治理制度(2010年10月)
2010.09.14
自力董事对《关于使用部分超募资金永世性增补公司流动资金的议案》的自力意见
2010.09.14
外部信息报送和使用治理制度(2010年9月)
2010.07.31
自力董事关于控股股东及其他关联方占用公司资金、公司对外担保情形的专项说明和自力意见
2010.07.06
公司章程(2010年7月)
2010.06.19
子公司治理制度(2010年6月)
第一页
上一页
21
22
23
24
25
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】